Emerging Implant Technologies GmbH (EIT), a German medical 3D printing enterprise, has announced an important contract with the largest group purchasing organization (GPO) in the United States.
Working with Ortho Sales Partners, EIT has successfully concluded the contracting process with HealthTrust related to an HCA contract.
The Hospital Corporation of America (HCA) has 177 hospitals and 119 surgery centers located in 20 states and the United Kingdom. Annually approximately five percent of all U.S. hospital services take place at an HCA facility.
Improving spine care with 3D printing
EIT offers a portfolio of Smart Spinal Implants™ that are based on 3D printing EIT Cellular Titanium®. The material is available for the cervical and lumbar spine, with an extensive choice in footprint sizes, heights and lordosis angles to support the recreation of sagittal balance and alignment. Since 2014 over 12.000 EIT cases have been performed in over 15 markets globally.
The deal means that EIT can offer interbody products for Cervical, ALIF, TLIF and PLIF procedures. Work is currently underway with HCA leadership to understand the economic impact of additive manufacturing for the medical sector. The project will examine fusion rates, implant costs and the need for high cost osteobiologics.
In 2016, EIT received investment from private equity and venture capital firm SHS Gesellschaft für Beteiligungsmanagement mbH, announcing at the time they would use the funds to expand international markets.
In July 2017, EIT 3D printed Cellular Titanium® spinal support implants received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Josh Sandberg, President of OSP said, “This is a huge milestone that we have been able to help achieve at an unusually early stage in EIT’s development. That is a credit to the strength of this product offering and we are excited about the opportunity to work with HCA facilities in helping them lower the overall cost of these spine procedures.”
“EIT´s goal is to improve spine care using the advantages of 3D printing technology and cope with given pricing and reimbursement structures. We are delighted that HCA/HealthTrust is interested in working with EIT. This will help us to get quicker market access in the United States” said Guntmar Eisen, cofounder and CEO of EIT.
Recently the FDA issued updated guidance about the medical use of 3D printing. You can read more about how additive manufacturing experts responded to the news here.
We want to know the most notable medical applications of 3D printing. Tell us and make your nomination for the 2018 3D Printing Industry Awards here.